Search

The European Science Foundation is to help the ten central and eastern European countries integrate their social sciences into the enlarged European Research Area.

Novo Nordisk is doing its bit to reverse the Danish brain drain, offering a number of “return” fellowships to attract highly qualified expatriates back to Denmark.

The claim that over-patenting hinders the development of new treatments is not supported by the evidence, says the US Biotechnology Industry Organization.

A significant number of applications for the first round of grants from the newly established European Research Council have come from senior scientists currently living in non-EU countries.

European policymakers are largely to blame for the sorry state of innovation in Europe, according Microsoft’s chief research and strategy officer.

The US biotechnology industry has gone through more than three years of sustained IPO financings, but that news isn’t all rosy for the industry.

The technology funding gap has long been with us, but in drug discovery it has widened into a chasm.

IPOs are up in the year to date. But the value of these deals is down. Rather than cashing out, VCs are getting a ticket to stay on for a white-knuckle ride.